Latest Regulatory News

Cynata Therapeutics is advancing three pivotal clinical trials targeting acute Graft versus Host Disease, osteoarthritis, and kidney transplantation, with major results expected through early 2026. The company maintains a solid cash position supporting its clinical pipeline and strategic growth.

Sequoia Financial Group has responded to an ASX price query, denying any undisclosed material information behind recent trading fluctuations and reaffirming compliance with listing rules amid ongoing ASIC investigations.

CurveBeam AI reported a solid 18% increase in purchase orders for FY25, alongside record cash receipts and positive operational cash flow in Q4. The company is also advancing a significant vendor financing facility to support growth in key markets.

Prescient Therapeutics has secured FDA Fast Track designation for PTX-100 in treating relapsed Cutaneous T-Cell Lymphoma and dosed the first patient in its Phase 2a trial, supported by a recent $6.8 million capital raise.

Bowen Coking Coal has appointed voluntary administrators after failing to secure fresh capital or negotiate with key creditors, reflecting mounting challenges in Queensland's coal sector. The administration aims to enable a sale or recapitalisation while maintaining operations at its Burton Mine Complex.

Westar Resources’ June quarter report reveals intriguing molybdenum, bismuth, and tungsten anomalies at its Mageye prospect, prompting a strategic review of exploration plans amid a solid $1.2 million cash position.

Bass Oil reported steady oil production and a significant cash reserve increase in the June quarter, while strategically acquiring the Vanessa gas field to pivot towards gas production.

CurveBeam AI reported a strong Q4 FY25 with record customer receipts and an 18% rise in purchase orders, while advancing key regulatory milestones and securing a major financing facility.

Magnetite Mines has increased its Razorback iron ore resource estimate and extended key partnership negotiations, advancing its flagship project’s development. The company also reported promising metallurgical testwork and drew down funding to support ongoing feasibility studies.

Critica Limited reports significant progress on its Jupiter Rare Earths Project, unveiling a 95% mass reduction in beneficiation testwork and appointing a new CEO to drive development.

Javelin Minerals reports a significant 27% increase in indicated gold resources at its Eureka project, advancing plans for mining and early cash flow amid strong drilling results.

Central Petroleum Limited has announced an on-market share buy-back program of up to 10% of its issued shares, supported by robust cash flows from new multi-year gas sale contracts and existing reserves.